EVENTIDE ASSET MANAGEMENT LLC 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:18 pm Sale | 2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | EVENTIDE ASSET MANAGEMENT LLC | 3,332,005 5.030% | -298,008 (-8.21%) | Filing |
| 2024-02-14 11:48 am Purchase | 2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | EVENTIDE ASSET MANAGEMENT LLC | 3,630,013 6.640% | 3,630,013 (New Position) | Filing |